The use of chatbots is increasing due to a shortage of mental health professionals, with some U.S. insurers, universities, and hospital chains offering similar programs. However, concerns have been raised about their ability to recognize suicidal thinking and emergency situations. Some experts argue that the FDA should regulate chatbots, while others believe that the focus should be on incorporating mental health services into general checkups and care rather than offering chatbots.
Key takeaways:
- Mental health chatbots like Earkick are being used as a form of self-help for people dealing with anxiety and stress, but they are not considered a form of therapy.
- These AI-based chatbots are not regulated by the FDA as they do not claim to diagnose or treat medical conditions, raising concerns about their effectiveness and safety.
- Some health professionals believe chatbots can be beneficial due to the shortage of mental health professionals, and they are being used by some health services and insurers.
- There is limited data on the effectiveness of these chatbots in improving mental health, and concerns have been raised about their ability to recognize suicidal thinking and emergency situations.